Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A
Background. RA patients have a higher incidence of cardiovascular diseases compared to the general population. Serum amyloid A (SAA) is an acute-phase protein, upregulated in sera of RA patients. Aim. To determine the effects of medications on SAA-stimulated human coronary artery endothelial cells (...
Saved in:
Main Authors: | K. Lakota, D. Hrušovar, M. Ogrič, K. Mrak-Poljšak, S. Čučnik, M. Tomšič, B. Božič, P. Žigon, S. Sodin-Semrl |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2018/8237209 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Amyloid Alpha in Parapneumonic Effusions
by: Vagelis Boultadakis, et al.
Published: (2011-01-01) -
Association of Serum Alpha-Tocopherol and Retinol with the Extent of Coronary Lesions in Coronary Artery Disease
by: Carolinne Thaísa de Oliveira Fernandes Miranda, et al.
Published: (2018-01-01) -
Haptoglobin and serum amyloid a in subacute ruminal acidosis in goats
by: F.H.D. González, et al.
Published: (2010-01-01) -
Dual Effect of Serum Amyloid A on the Invasiveness of Glioma Cells
by: Franciele Hinterholz Knebel, et al.
Published: (2013-01-01) -
Influence of Polymorphism on Glycosylation of Serum Amyloid A4 Protein
by: Toshiyuki Yamada, et al.
Published: (2014-01-01)